1. Home
  2. GRFS vs NEU Comparison

GRFS vs NEU Comparison

Compare GRFS & NEU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRFS
  • NEU
  • Stock Information
  • Founded
  • GRFS 1940
  • NEU 1887
  • Country
  • GRFS Spain
  • NEU United States
  • Employees
  • GRFS N/A
  • NEU N/A
  • Industry
  • GRFS Biotechnology: Pharmaceutical Preparations
  • NEU Major Chemicals
  • Sector
  • GRFS Health Care
  • NEU Industrials
  • Exchange
  • GRFS Nasdaq
  • NEU Nasdaq
  • Market Cap
  • GRFS 6.6B
  • NEU 7.4B
  • IPO Year
  • GRFS 2006
  • NEU N/A
  • Fundamental
  • Price
  • GRFS $9.57
  • NEU $750.00
  • Analyst Decision
  • GRFS Hold
  • NEU
  • Analyst Count
  • GRFS 1
  • NEU 0
  • Target Price
  • GRFS $10.30
  • NEU N/A
  • AVG Volume (30 Days)
  • GRFS 522.4K
  • NEU 89.6K
  • Earning Date
  • GRFS 01-01-0001
  • NEU 10-30-2025
  • Dividend Yield
  • GRFS 1.48%
  • NEU 1.42%
  • EPS Growth
  • GRFS 132.60
  • NEU 17.77
  • EPS
  • GRFS 0.53
  • NEU 50.47
  • Revenue
  • GRFS $8,744,226,659.00
  • NEU $2,779,049,000.00
  • Revenue This Year
  • GRFS $5.46
  • NEU N/A
  • Revenue Next Year
  • GRFS $6.69
  • NEU N/A
  • P/E Ratio
  • GRFS $23.80
  • NEU $15.32
  • Revenue Growth
  • GRFS 9.32
  • NEU 2.27
  • 52 Week Low
  • GRFS $6.19
  • NEU $480.00
  • 52 Week High
  • GRFS $11.14
  • NEU $875.97
  • Technical
  • Relative Strength Index (RSI)
  • GRFS 44.36
  • NEU 33.02
  • Support Level
  • GRFS $9.39
  • NEU $775.31
  • Resistance Level
  • GRFS $9.86
  • NEU $801.45
  • Average True Range (ATR)
  • GRFS 0.19
  • NEU 23.37
  • MACD
  • GRFS 0.00
  • NEU -10.28
  • Stochastic Oscillator
  • GRFS 33.32
  • NEU 7.18

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About NEU NewMarket Corp

NewMarket Corp is a holding company that, through its subsidiaries, manufactures and sells petroleum additives. Petroleum additives are used in lubricating oils and fuels to enhance their performance in machinery, vehicles, and other equipment. It comprises two broad product applications. Lubricant additives are formulated chemical solutions that, when blended with base fluids, improve the efficiency, durability, performance, and functionality of mineral oils, synthetic oils, and biodegradable fluids. Fuel additives are chemical components that help oil refiners meet fuel specifications or formulated packages that improve the performance of gasoline, diesel, biofuels, and other fuels.

Share on Social Networks: